CIPLOX
250MG TBL FLM 50(5X10)
| SÚKL code | 0015654 |
|---|---|
| Name of the product | CIPLOX |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | CIPLOX |
| Supplement | 250MG TBL FLM 50(5X10) |
| Strenght | 250MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 50(5X10) |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE (CIPROFLOXACINI HYDROCHLORIDUM MONOHYDRICUM) |
| ATC group | J01MA02 |
| ATC group name | CIPROFLOXACIN |
Marketing authorisation information
| Registration Number | 42/1236/97-C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 07. 2019 |
| MA Holder | Cipla (UK) Limited, Addlestone |
| MA Holder country | VELKÁ BRITÁNIE |
| Actual MA holder | Cipla Europe NV, Antverpy |
| Actual MA holder country | BELGIE |
cz